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The therapeutic use of natural herbs is an ancient human civilization act and the numbers of people have reliance on their
pharmacological properties and preferred to use the natural herbs. People also use to consume these herbs as supplements to
energize, bolster, and eventually enhance sexual ability. Polyherbal formulation (PHF) is one of these herbal amalgams that can be
used to treat sexual dysfunction including erectile dysfunction, impotence, ejaculation dysfunction, and hypogonadism. The pilot
study was aimed at evaluating the capacity of PHF in enhancing the spermatogenic potential of oligospermic patients. Thirty-six
male patients with oligospermia were enrolled and randomized either to treatment (n = 23) with PHF (750mg/d in three doses
for 90 days) or to placebo (n = 13) in the same protocol. The preintervention semen analysis was compared with posttreatment
semen analysis. Based on the postintervention semen analysis, patients were advised to undergo either in vitro fertilization (IVF)
or intracytoplasmic sperm injection (ICSI) to assess their fertility status. After polyherbal treatment, there was a 256% increase in
sperm concentration (9.59 ± 4.37 × 106/mL to 25.61 ± 8.6 × 106/mL; P ≤0.001), 154% increase in semen volume (1.7 ± 0.14mL
to 4.32 ± 0.38mL; P ≤0.001), and 215% increase in sperm motility (15.43 ± 2.40% to 48.65 ± 5.10%; P ≤ 0.001) on day 90 from
baseline. Furthermore, a significant improvement and regulation were also observed in serum hormone levels with PHF treatment
as compared to the placebo group. The present study demonstrated the evidence on synergistic spermatogenic effect of PHF as
attributed in ayurveda for the treatment of oligospermia leading to infertility.
1. Introduction
Among human infertility, male infertility accounts for almost
50%. Among 40% to 50% of these infertile males, the
etiologies remain unidentified [1–7]. Approximately 8% of
these infertile men are looking forward to medical treatment
to resolve infertility related issues [8]. Male infertility is
caused by a wide range of etiologies. Numerous factors
are defined with unequivocal and harmful effect on male
reproduction function, i.e., (i) modern (sedentary) life style
problems like obesity, smoking, caffeine, alcohol, and drug
abuse, (ii) nutritional deficiencies including vitamin and
mineral deficiencies [9] and oxidative stress [10], (iii) genetic
causes related to male infertility like the cystic fibrosis
transmembrane conductance regulator (CFTR) gene muta-
tions leading to congenital absence of the vas deferens,
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Y-chromosome microdeletions in the azoospermia factor
locus leading to spermatogenic impairment, and karyotype
abnormalities, oncological diseases, (iv) hormonal issues
encompass: hyperprolactinemia, hypothyroidism, congenial
adrenal hyperplasia, hypogonadotropic hypogonadism, and
panhypopituitarism, (v) physical problems likewise varico-
cele, damaged sperm ducts, torsion, Klinefelter’s syndrome,
retrograde ejaculation, psychological issues comprised of
erectile dysfunction, premature ejaculation, and ejacula-
tory incompetence [11, 12]; hence, different approaches are
required to resolve all these multifaceted dilemmas [13].
Oligospermia may be considered as a pathologic effect of
the above-mentioned causes and consequently oligospermia
represents a cause of reduced male fertility [1, 2].
Broad range of strategies had been carried out to over-
come the male infertility complications. Human chorionic
gonadotropin (hCG) [14], treatment of follicle-stimulating
hormone (FSH) [15], and usage of assisted reproduction
technology (ART) are of the state-of-the-art options for these
infertility issues [16]. However, shortcomings of the above
stated treatments cannot be overlooked, which may include
acceptability, high expenditure, and threat of diverse compli-
cations during surgical procedures [17]. Approximately half
of the couples undergoing consultation for male infertility
terminated ART treatment, mainly due to the physical and
emotional pain resulting from the treatment [16]. Addition-
ally, there were some concerns for the offspring conceived
by means of ART, including in vitro fertilization (IVF) and
intracytoplasmic sperm injection (ICSI) via microsurgical
epididymal sperm aspiration (MESA) or percutaneous epi-
didymal sperm aspiration (PESA) showed a higher risk of
birth defects [11, 18]. Furthermore, many people over the
globe consumed locally grown plants/herbs as nutritional
supplements and various therapeutic herbal formulas have
been clinically evaluated and approved for fabrication of
drugs in developed and developing countries to energize,
bolster, and enhance sexual ability eventually to treat various
sexual disorders [17, 19–21]. In the outlook of oligospermia,
diverse indigenous herbs have been claimed to have sexual
arousal effect or even useful for the management of low
sperm count [22–27]. However, these herbs proved limited
potential for improving the major assessed parameters for
semen; in addition less literature has been cited for potential
herbal remedy for oligospermia [28–36]. Therefore, there
is an immediate need to fabricate a safe and cost-effective
therapeutic drug from novel natural sources that devoid of all
limitations stated above from modern medicines or/medical
techniques and herbal remedies.
Since PHF due to their synergistic effects and multiple
biological functions demonstrated the vast advantages over
single herbal formulation, therefore, in the present investi-
gation, a PHF was made, based on recommended ayurvedic
practicing knowledge/literature citation, which is root of
Chlorophytum borivilianum, seeds of Hygrophila spinosa T.
Anders, seeds of Mucuna pruriens, seeds of Mimosa pudica,
sap of Acacia senegal, root of Astragalus membranaceus,
seed coat of Plantago ovate, sap of Bombax ceiba, and
root of Eurycoma longifolia and nonherbal constitute called
“rock candy”. All stated constituents were fabricated into a
therapeutic PHF to determine the effects on men infertility.
Although, there were several evidences on animal models
regarding the sex-stimulating effect of above stated herbs on
male fertility and sperm quality and other combination of
herbs [28–38]. However no clinical trial has been performed
yet to investigate the spermatogenic effect on human. For
the reason, a proposed research trial was conducted to deter-
mine the synergistic spermatogenic potential of polyherbal
formulation on reproductive function of oligospermic male
patients.
2. Material and Methods
Ethics Statement.This study was approved by the Institutional
Review Board on Human Research of University of Lahore
Teaching Hospital, Lahore, Pakistan, with reference num-
ber (IRB-UOL-FAHS/B00112A). The study was conducted
according to the declaration of Helsinki principles. Written
informed consent for evaluation and use of their clinical data
for scientific purposes was obtained from each patient prior
to recruitment.
2.1. Polyherbal Formulation. In the present investigation,
PHF was made by combining the root of Chlorophytum
borivilianum, seeds of Hygrophila spinosa T. Anders, seeds
of Mucuna pruriens, seeds of Mimosa pudica, sap of Acacia
senegal, root of Astragalus membranaceus, seed coat of Plan-
tago ovate, sap of Bombax ceiba, root of Eurycoma longifolia,
and rocky candy in a ratio of 1:1:1:1:1:1:1:1:1:8 respectively
(Table 1), to determine the effect of the prepared formulation
on oligospermic patients.
2.2. Preparation of Extract. Samples were thoroughly washed
with deionized water to remove any contamination, ground
to make crude powder with the help of liquid nitrogen
followed by individual ethanol, methanol, acetone, and water
extraction. Solvents are selected based on their polarities,
from high to low (i.e., water>methanol>ethanol>acetone)
as different classes of bioactive compounds possessed dif-
ferent affinities towards the solvents of different polari-
ties.
For the extraction, an aliquot of crude powder (5 g)
was accurately weighed into four 250-mL flasks and shaken
overnight (16–20 h) with 50ml of ethanol, methanol, ace-
tone, and water individually in ratio of 1:10 at room tem-
perature. After the overnight shaking, all samples were
centrifuged at 4000 rpm for 10 minutes, followed by the
vacuum filtration of supernatant through Whatman paper
No. 1 (x2). The residue was then resuspended in another
50ml of ethanol methanol, acetone, and water, respectively.
The process was repeated twice. The combined filtrate was
transferred to a preweighted glass plate and the organic
solvents were evaporated by placing at hot air oven at
40∘C for 4 hours after which freeze-drying of filtrate was
performed using an Alpha 1–4 LD plus freeze-drying unit
(Labconco, Germany). After lyophilization, dry weight of
sample was recorded and stored at −80∘C for further
usage.
BioMed Research International 3
Table 1: Composition of polyherbal formulation.
Scientific Name Extraction material Quantity (g/100 g of formulation) Active Principles
Chlorophytum borivilianum Roots 5.88 Alkaloid, steroids
Hygrophila spinosa T. Anders seeds 5.88 Terpenoids, phenolics
Mucuna Pruriens Seeds 5.88 Alkaloids
Mimosa pudica Seeds 5.88 Flavonoid, terpenoids,glycosides, alkaloids
Acacia senegal Sap of tree 5.88 Polysaccharides
Astragalus membranaceus Roots 5.88 flavonoids
Plantago ovata Seed Coat 5.88 Psyllium mucilloid
Bombax ceiba Sap of tree 5.88 Flavonoids, terpenoids
Eurycoma longifolia Roots 5.88 Alkaloids, phenolics
Supersaturated Solution of Sugar
and Water --- 47.05 ---
2.3. Standardization of Polyherbal Formulation (PHF). PHF
was standardized as per WHO guidelines. Thin Layer Chro-
matography (TLC) was executed for three different batches,
and the Rf value was determined for standardization parame-
ters. Quantitative analysis of rawmaterial was also carried out
for organoleptic characteristics, physicochemical parameters,
and toxicological parameters.
2.4. Sample Collection and Laboratory Methodology. Semen
sample was collected at morning by patient masturbation
into sterile plastic specimen cup in the hospital and all
semen values were determined with compliance with World
Health Organization (WHO) recommendations at the time
of recruitment [39, 40]. Subjects were instructed to abstain
from ejaculation for at least 72 hours prior to producing the
semen samples. Samples were left to liquefy for 30 minutes
but no longer than one hour prior to performing the semen
analysis. To determine semen volume, samples were left to
liquefy in an incubator at 37∘C, 5%CO
2
for 30minutes before
volumewasmeasured, and sperm concentration andmotility
parameters were measured by means of computer assisted
semen analyzer (CASA) (Hamilton-Thorne Version 10HTM-
IVOS) using 2 Chamber Leja slides (Leja, The Netherlands).
Setting parameters and the definition of measured sperm
motion parameters for CASA were established by the manu-
facturer. A 5𝜇l well-mixed, homogeneous samplewas applied
to each chamber of the Leja slide. Two known concentrations
of Accu-bead + (Hamilton-Thorne, Inc., Beverly, MA, USA)
were used each day for quality control and to confirm
accuracy of the CASA counting. The Leja slide was placed
on the warm CASA stage and analyzed. A manual count
of the same sample was also performed and discrepancies
>10% required a repeat count. On manual count, sperm
concentration was obtained by averaging the total number of
sperm in both chambers on the Leja slide. At least 100 sperm
cells were counted for motility assessment. Reference values
from the World Health Organization (WHO) were used to
assess sperm concentration and motility [39]. Testosterone,
LH and FSH levels of blood serum were assessed using
the Immulite automated chemiluminescence immunoassay
analyzer (Immulite; Diagnostic Products Corp., Los Angeles,
CA, USA) according to manufacturer’s instructions, at Uni-
versity of Lahore Teaching Hospital. For IMMULITE 1000
system analytical sensitivity was 0.1 IU/L for both LH and
FSH. The intra- and interassay CVs were 6.3 and 9.4% for
testosterone, 4.0 and 7.1% for LH, and 4.2 and 8% for FSH.
2.5. Subjects. This double blind, two-armed, placebo-
controlled, randomized, comparable group trial with
1: 1 arbitrary allocation was prospectively conducted at
University of Lahore Teaching Hospital, Punjab, Pakistan,
between September 2016 and December 2016. Out of
ninety-one (91) patients, thirty-six (36) oligospermic
patients were selected for the current clinical trial after
predefined scrutiny. All participants in both groups were
neither alcoholic nor user for any tobacco product. All
oligospermic patients between the ages of 22 and 40 years
were registered after acquiring the written approval from
them; they also had a background of accustomed sexual
intercourse over 12 months with a sexually normal female
partner. All oligospermic patients exhibited the sperm count
between the range of 0.0 to 15.0million /mL. Subject with
a total sperm count below the 0.0million/mL or greater
than 15million/mL were not considered. Subject having
cardiovascular diseases (CD), erectile dysfunction (ED),
varicocele, testicular hypertrophy, uncontrolled diabetes
mellitus (DM), obesity, precise hepatic or renal disorder, and
cerebrovascular problems or with previous history of partly
obstructive oligospermia, pelvic fractures prosthetic surgery
on the penis, and cryptorchidism were also debarred from
the current clinical trial. Oligospermic patients with known
allergic reaction to any constitute of polyherbal extract were
also not included.
2.6. Randomization and Treatments. The subjects for trial
were randomized to PHF treated group (n = 23) and placebo
group (n = 13). The oligospermic patients in PHF treated
group were administered 3 capsules per day (containing
250mg of high spectrum of PHF-extract) orally for a period
of 3 months (90 days) on the other hand, capsules containing
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250mg of corresponding placebo were given in the same way
to the placebo group.
The constituents used for formulation of polyherbal
extract for the current trial had been extracted with an exclu-
sive processing technology for developing a great phytophar-
maceutical feature that amplified the action of PHF-extract
manifolds, ultimately providing pan-therapeutic effects.
2.7. Trial Visit and Assessments. Throughout the treatment
phase of 90 days (3 months), the subjects were mandatory to
present themselves at the trial hub at specified intervals: Visit
01 on Day 60 and Visit 02 on Day 90 (3 months). Complete
physical examination was conducted at baseline (Day 0),
height and weights were measured by physician balance
beam scale with height rod, while respiratory rate blood
pressure and body temperature were assessed by Vital Signs
Monitoring System (VSMS) and semen analysis was done
at predefined time intervals likewise at Day 0, then after 60
days and 90 days. Semen analyses were performed according
to World Health Organization 2010 criteria [39, 40]. Serum
testosterone, luteinizing hormone (LH), and serum follicle-
stimulating hormone (FSH) levels were evaluated on Day 0
(baseline) and then after Day 90. The principal (primary)
usefulness result was the advancement in the major semen
parameters and serum hormone level from baseline (Day 0)
after 90 days of treatment.
2.8. Statistical Methods. In the current study, placebo group
and PHF treated groups were evaluated for change in the
semen parameters from the baseline (Day 0) by using one-
way ANOVA (with treatment as a factor). The acquired
outcome was taken as insignificant if the P value exceeded
to 0.05.
3. Results
3.1. Composition of Polyherbal Formulation. Recently, poly-
herbal formulations (PHFs) are gaining importance all over
the globe due to their dynamic medicinal and therapeutic
claims and demonstrated vast advantages over single herbal
formulations (SHFs), in the outlook of aforementioned
claims; we have prepared a novel polyherbal formulation
(PHF) to recover the male patients from oligospermia, and
its composition is described in Table 1.
3.2. Standardization of Polyherbal Formulation (PHF). TLC
was run for the ethanolic extract in the solvent system
ethanol/acetone/water at 17:2:1 ratio and plates were visual-
ized directly after drying under UV at 254 nm and 366 nm
in UV TLC viewer and then sprayed the TLC plates with
a solution of 37% formaldehyde in conc. sulfuric acid (1:10)
(for alkaloids), 1% ethanolic solution of aluminum chloride
(for flavonoids), and p-anisaldehyde-sulfuric acid reagent
(for phenols, sugars, steroids, and terpenoids) according to
standard protocols. There were six spots evidently observed
in all three batches and Rf values were calculated as 0.82,
0.77, 0.7, 0.67, 0.53, and 0.31 in each replicate. All other
factors likewise organoleptic characteristics, physicochemical
parameters, and toxicological parameters were also compli-
ance withWHO recommendations and elaborated in Table 2.
3.3. Demographic Parameters and Participants Distribution.
Ninety-one infertile males (n= 91) were taken into consid-
eration for a proposed research study. Thirty-six (n= 36)
were finally selected for clinical trial. This trial demonstrated
the statistics of those 36 oligospermic patients that were
double blind randomly distributed into two groups, i.e., the
high-concentration PHF treated group (n = 23) and placebo
group (n = 13). The two groups were comparable in terms
of demographic parameters and demonstrated all vitals in
optimum range (Table 3).
3.4. Semen Parameters. PHF treated group showed a highly
significant (P ≤ 0.001) enhancement in sperm concentration
after 90 days (3months) of treatment as compared to the base-
line value onDay 0 of the current trial (Figure 1(a)).The boost
in sperm concentration was from 10.04 ± 3.21 × 106/mL to
35.82±5.11× 106/mL, corresponding to a percentage increase
of 256%. A significant augmentation was also recorded in the
semen volume (from 1.7±0.14mL to 4.32±0.38mL;P≤0.001)
(Figure 1(b)) and sperm motility (from 15.43 ± 2.40% to
48.65±5.10%;P ≤ 0.001) (Figure 1(c)) onDay 90 (3months) in
contrast to the baseline value on Day 0. These corresponded
to increases of 154% and 215%, respectively.
3.5. Serum Hormone Levels. Moreover, serum hormones
levels were also improved appreciably likewise testosterone
level had been boosted up by 112% (from 3.65 ± 0.71 ng/mL
to 7.76 ± 0.85 ng/mL; P ≤ 0.001) (Figure 2(a)) and LH by
69% (from 3.38 ± 0.91mIU/mL to 5.73 ± 1.32mIU/mL; P
≤0.05) (Figure 2(b)) while FSH level had been declined by
37% (from 26.45 ± 7.90mIU/mL to 16.65 ± 4.21mIU/mL; P
≤0.05) (Figure 2(c)) with subsequent treatment with PHF-
extract, in contrast to the baseline (Day 0) values of these
parameters.
4. Discussion
Infertility is defined as not being able to achieve pregnancy
(conceive) after one year of isolated sex with the same
partner. One year is lower reference limit (LRL) time for
conceive decided by the World Health Organization [3, 41,
42]. Among infertility,male infertility accounts for about 50%
of human infertility and considered to be less complicated
than female infertility [3, 4, 43]. Several investigations had
earlier confirmed that undermined semen production and
sperm quality are amid the imperative causative factors for
male infertility [5, 6]. In addition to different physical defects,
oligospermia is the widespread cause of male infertility in
more than 90% of the cases. Out of these, about 30 to 40%
causes are unexplained, and in the rest of the cases critical
illness, genetic abnormalities, malnutrition, pollution, side
effects of some medicines, hormones, and chemicals play
a key role in infertility [1, 2]. In the present investigation,
we formulated a polyherbal formulation (PHF) based on
previous therapeutic scientific endeavors for the critical
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Table 2: Standardization of polyherbal formulation (capsule).
Name of Test Observations
Organoleptic characteristics
Description Grayish brown colored Powder filled in blue cap/red body, 0 sized capsule
Color Grayish brown
Odor Characteristics
Taste Slightly Sweet
Physicochemical Parameters
pH 7.6
Moisture Contents (%) 1.04
Average Weight (mg) 251
Weight Variations (Mean ± SEM) 249-253
Loss on drying (%) 1.2
Total ash (%) 6.54
Water soluble ash (%) 3.85
Acid-insoluble ash (%) 1.4
Ethanol Soluble Extractive value (%) 19.45
Methanol Extractive value (%) 15.02
Water Soluble Extractive value (%) 13.34
Toxicological Parameters
Arsenic (ppm) 1.0 ppm
Lead (ppm) 0.5 ppm
Total microbial count NMT 1000 cfu/g 105 cfu/g
Yeasts and molds Nil
Presence of E. coli Absent
Presence of Streptococcus Absent
Presence of Salmonella Absent
Presence of Pseudomonas Absent
Table 3: Demography and baseline data of the study subjects.
Parameters Placebo PHF- Treated
Age (yr) 28.53 ± 3.83 29.78 ± 4.75
Height (cm) 165.46 ± 9.05 165.47 ± 12.30
Weight (Kg) 72.46 ± 6.04 75.91 ± 7.10
Pulse (per min) 79.53 ± 6.56 81.39 ± 6.06
Respiratory Rate (per minute) 14.6 ± 1.45 14.34 ± 1.61
Systolic Blood Pressure (mm Hg) 123.66 ± 7.06 125.82 ± 4.09
Diastolic Blood Pressure (mm Hg) 84 ± 3.46 84.47 ± 2.59
Body Temperature (∘F ) 98.54 ± 0.30 98.60 ± 0.41
oligospermic patients to recover their sexual potency. Among
the key ingredients, we selected Chlorophytum borivilianum
due to its aphrodisiac action, used to cure impotency and
sterility and enhance male sexual potency ultimately for the
treatment of certain forms of sexual inadequacies, such as
premature ejaculation and oligospermia [28, 44]. Similar
kinds of findings were also reported earlier, as discussed
below in detail, by various investigators, and highlighted
their positive outcomes on the oligospermia and different
semen parameters using in vitro/in vivo model systems
for Hygrophila spinosa T. Anders [29], Mucuna pruriens
[30], Mimosa pudica [31], Acacia Senegal [32], Astragalus
membranaceus [33], Plantago ovate [34], Bombax ceiba [35],
and Eurycoma longifolia [36].
To the best of our acquaintance, this is the first demon-
stration to explore the synergistic efficacy of our prepared
PHF on human clinical trial, which leads to the improve-
ment in the major semen parameters of oligospermic males
compared with placebo group. In this clinical study, we
noticed highly significant improvements in major assessed
parameters of semen such as sperm concentration, semen
volume, and sperm motility in PHF treated group compared
to placebo group. Serum hormones like testosterone, LH,
and FSH were also markedly improved. Serum testosterone,
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Figure 1: (a) Sperm concentration (×106/mL), (b) semen volume (mL), and (c) sperm motility (%) in the full-spectrum PHF treated group
and placebo group including oligospermic males. ∗∗P ≤ 0.001 as compared to baseline values on Day 0 of the study duration of 3 months.
Values are expressed as mean ± SD.
LH, and FSH are the hormonal markers of androgenicity
[45]. An elevated FSH level is generally designated to severe
seminiferous epithelium damage [11] and it is inversely cor-
related with sperm concentration motility and morphology
[46]. Among these biomarkers the serum testosterone and
LH levels were increased up to 112% and 69%, respectively,
and conversely FSH level was declined up to 37% in PHF
treated group as compared to placebo group. The boost in
serum testosterone and LH level and drop in FSH level may
be predominantly attributed to herb Mucuna pruriens as it
was documented thatMucuna pruriens increased epididymal
alkaline phosphatase activity, protein level in epididymis,
serum testosterone, LH, dopamine, adrenaline, and nor-
adrenaline levels in infertile men and reduced the levels of
FSH and PRL (Prolactin) [30, 47] and ultimately enhanced
spermatogenesis due to the presence of high contents of
alkaloids [48, 49]. Many authors also cited the antioxidant,
antitumor, and anti-inflammatory impending of alkaloids
[44].The escalation in serum testosterone is also endorsed to
another herb calledEurycoma longifoliawhichwas previously
reported for its ability to activate 17 𝛼-hydroxylase/17, 20
lyase (CYP17) enzyme that would augment testosterone level
[50]. In addition, another clinical study on human, also
declared that Eurycoma longifolia supplementation increased
BioMed Research International 7
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Figure 2: (a) Serum testosterone levels (ng/mL), (b) serum LH (mL IU/mL), and (c) serum FSH (mL IU/mL) in the full-spectrum PHF
treated group and placebo group including oligospermic males. ∗∗P ≤0.001 as compared to baseline values on Day 0 of the study duration of
3 months. Values are expressed as mean ± SD.
the level of testosterone [51]. An increase in testosterone
level has been associated with increase of sexual desire,
penile tumescence, and rigidity, as well as the accessory
muscles which help to strengthen and provide additional
sexual activity [52–54]. Research with various animal and
human models pointed out that there is a strong correlation
between sexual behavior and brain neurotransmitters like
dopamine, 5- hydroxytryptamine (5-HT), serotonin, and
nitrergic neurons [55]. The motor switch of ejaculation in
animals is also governed by serotonin and its receptors [56].
Testosterone may also expedite male sexual performance by
aggregative dopamine discharge in the medial preoptic area
and potentiating nitrergic neurotransmission in brain, which
ensued in stimulation of hypothalamic-pituitary-gonadal
axis [57, 58]. Hike in the testicular weight symbolizes the
number as well as sperms motility [59]. Increased serum
testosterone and LH levels and decreased FSH level after
administration of PHF could thus be considered as one of the
imparting factors accountable for the overall improved sexual
potential against oligospermia in all PHF treated groups
compared to placebo group.
The credit for a boost in endogenous testosterone
levels and enhancing male sexual behavior goes to pos-
sible bioactive agents present in our novel formulation.
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These bioactive components may be steroids, antioxidants,
saponins, peptides, organic acids, etc. and our future research
will be comprised of characterizing and elucidating these
novel bioactive compounds. The stated mechanisms of these
agents include steroids by rising androgen production [60,
61], flavonoids by augmenting testosterone synthesis or by
inhibiting its metabolic degradation [62, 63], alkaloids [52]
by dilating the blood vessels in the sexual organs [64],
and saponins by activating gonadal tissues and central ner-
vous system via NO-dependent mechanism [65]. Thus, the
improvements in sexual function established in the current
study might be due to the existence of such compounds in
our prepared PHF.
Sperm motility is also a very important factor for the
proper fertilization and conceivability. Sperm motility was
also significantly increased up to 215% as compared to
placebo group in our study.This increase is mainly accredited
by Astragalus membranaceus as at the dose of 10mg/ml; the
sperm motility in semen has increased up to 146.6 +/- 22.6%
of control and for washed sperm increased up to 138.2 +/-
13.8% of control [33].
Nevertheless, sperm count and semen volume were also
significantly increased up to 256% and 154%, respectively, in
PHF treated as compared to placebo group. It may due to
individual or synergistic activity of other PHF ingredients
which had demonstrated previously proven spermatogenetic
potential and aphrodisiac activity for alleviating oligosper-
mia. Likewise, seeds of Hygrophila spinosa T. Anderson
have spermatogenic effect which may be owing to the hor-
monal and neurohumoral changes, which play a vital role
in the sexual behavior and fertility disorders [29]. Mimosa
pudica seeds extract possesses protective, therapeutic, and
restorative capacity on the histoarchitecture of hypothalamic-
pituitary-testicular axis components [31]. Acacia Senegal
enhanced the semen quality and could protect testis via
improvement of antioxidant capacity; it may be useful to
overcome the diabetic fertility complications [32]. Plantago
ovate seed used in considerable quantity in PHF ultimately
facilitated recovering the oligospermia and subsidized the
male infertility [34]. Bombax ceiba root extract enhanced the
spermatogenesis, sexual behavior, and erectile function [35].
Eurycoma longifolia Jack plant may potentially be suitable for
themanagement of oligospermia andmale infertility [36, 66–
68]. Our finding is also more significant compared with
previously designed PHF which increased the sperm count
maximum up to 39% to 40.5% in different animal models
[37, 38].
It can be accomplished from above discussion that
our currently designed PHF demonstrated more significant
results compared with previous work on various animal
and human models for individual component of current
PHF or combination of two or more of other PHFs. In
addition, aforementioned PHF also revealed diverse advan-
tages over western medicine/medical techniques, i.e., higher
expenditure associated with assisted reproductive technol-
ogy (ART), ART affects patient’s physical and emotional
wellbeing may contribute psychological distress, caused
birth defects, and proved less live birth rate [11, 17–
36].
5. Conclusion
PHF could improve the quantity and quality of semen in a
statistically significant manner in oligospermia male adults
between the ages of 22 to 40 years, in comparison to the
placebo, when used for 90 days, at 750mg/d in three doses.
PHF does also improve the serum testosterone; LH; and FSH
level in a majority of PHF treated males, in comparison to
the placebo. The results suggested that the prepared PHF
may be a new auspicious novel therapeutic amalgamation,
which can be used to improve the spermatogenic potential
of many oligospermic infertile men. This spermatogenic
property may be due to possible synergistic action of selected
herbs’ parts used in the preparation of PHF. However, further
investigations are warranted to confirm and elucidate the
effect of PHF on semen parameters.
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